In this study, we evaluated CILP2 expression and its correlations with clinicopathological characteristics, such as tumor stages, and overall survival of CRC patients in TCGA, and furtherly verified using immunohistochemistry assay within human CRC tissues, which may provide a new potential molecular marker for prognostic use of the patients. Here, CILP2 is linked to neoplasm.